Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

API Product List 2024 services provided by Biophore India Pharmaceuticals Pvt Ltd

Biophore India Pharmaceuticals Pvt Ltd
API Product List 2024

PDF Upload Jan, 2025

Biophore, its subsidiary Zenara, receive first approval for Cannabidiol in India

15 May 2023

// HEALTH ET

Akums enters into a joint association with Leiutis & Biophore

01 Dec 2022

// ECONOMICTIMES

Zenara Pharma Launches Generic Of Paxlovid For COVID-19 In India

09 Sep 2022

// OUTLOOKINDIA

DATA COMPILATION
#PharmaFlow

Biophore

Contact Supplier

DCAT Week

Attending

Book a meeting

envelop Contact Supplier

Latest Content by PharmaCompass

radio-compass-blog/chinese-fda-registered-generic-facilities-gain-steam-india-maintains-lead-with-396-facilities

Xls

CATEGORY PAGE

Biophore India Pharmaceuticals Pvt Ltd

VISIT THE VIRTUAL BOOTH, Contact Details

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

Product List 2024, Corporate Presentation, API Product List 2024, FDF Product List 2019, GMP Certificate 2017

Product List 2024
Corporate Presentation
API Product List 2024
FDF Product List 2019
GMP Certificate 2017

VIDEO(s)

Research. Innovation. Collaboration, Biophore Interview at CPhI Worldwide 2019, Biophore Interview at CPhI Worldwide 2018

Research. Innovation. Collaboration
Biophore Interview at CPhI Worldwide 2019
Biophore Interview at CPhI Worldwide 2018

DIGITAL CONTENT

1 Interview #SpeakPharma, 1 Vlog #PharmaReel, 8 Corporate Content #SupplierSpotlight, 1 Data Compilation #PharmaFlow, 23 News #PharmaBuzz

1 Interview #SpeakPharma
1 Vlog #PharmaReel
8 Corporate Content #SupplierSpotlight
1 Data Compilation #PharmaFlow
23 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

168 All APIs, 138 USDMF, 25 CEP/COS, 10 EU WC, 30 NDC API, 133 Listed APIs

168 All APIs
138 USDMF
25 CEP/COS
10 EU WC
30 NDC API
133 Listed APIs

DEVELOPMENTS

10 Drugs in Development

10 Drugs in Development

INTERMEDIATES

4 ALL Intermediates

4 ALL Intermediates

FINISHED DOSAGE FORMULATIONS

69 FDF Dossiers, 7 FDA Orange Book, 62 Listed Dossiers

69 FDF Dossiers
7 FDA Orange Book
62 Listed Dossiers

KEY PRODUCTS

Cannabidiol, Cetrorelix Acetate, Cladribine, Cysteamine Bitartrate, Cysteamine Hydrochloride, DOTA, Edaravone, Gadobutrol, Gadoteridol, Glycerol Phenylbutyrate, Iohexol, Mexiletine, Naphazoline Hydrochloride, Naphazoline Nitrate, Nelarabine, Nirmatrelvir, Procainamide Hydrochloride, Prochlorperazine, Prochlorperazine Edisylate, Prochlorperazine Maleate, Prucalopride Succinate, Regadenoson Monohydrate, Sapropterin Hydrochloride, Sodium Thiosulfate, Temozolomide, Valsartan

Cannabidiol
Cetrorelix Acetate
Cladribine
Cysteamine Bitartrate
Cysteamine Hydrochloride
DOTA
Edaravone
Gadobutrol
Gadoteridol
Glycerol Phenylbutyrate
Iohexol
Mexiletine
Naphazoline Hydrochloride
Naphazoline Nitrate
Nelarabine
Nirmatrelvir
Procainamide Hydrochloride
Prochlorperazine
Prochlorperazine Edisylate
Prochlorperazine Maleate
Prucalopride Succinate
Regadenoson Monohydrate
Sapropterin Hydrochloride
Sodium Thiosulfate
Temozolomide
Valsartan

SERVICES

API Manufacturing, Drug Product Manufacturing, API & Drug Product Development

API Manufacturing
Drug Product Manufacturing
API & Drug Product Development
- 2 API Development
- 3 Formulation Development

EXCIPIENTS

5 All Excipients, 5 USDMF

5 All Excipients
5 USDMF

INSPECTIONS & REGISTRATIONS

2 FDA, 5 EDQM, 2 GDUFA

2 FDA
5 EDQM
2 GDUFA

PI90230

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!